Stay updated on SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    6 days ago
    No Change Detected
  3. Check
    13 days ago
    No Change Detected
  4. Check
    20 days ago
    Change Detected
    Summary
    Only the revision tag changed from v3.2.0 to v3.3.2; no core content appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T11:41:34.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A government funding/operating-status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:14:00.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    No substantive updates to the study details were observed; differences appear limited to formatting or visual layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:17:39.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government operating-status notice; removed the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-06T05:56:15.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Page updated to v3.1.0; removed the Ovarian cancer resource and old v3.0.2 reference.
    Difference
    0.3%
    Check dated 2025-09-29T03:13:11.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    Revision: v3.0.2 added; v3.0.1 removed; 'Back to Top' removed. Overall, a minor update with no substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-14T19:58:07.000Z thumbnail image

Stay in the know with updates to SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial page.